Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'

February 4, 2013 2:33 PM EST Send to a Friend
Last Friday, Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) stock dropped 22 percent. The massive selloff is being tied to $65 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login